Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel for prevention of late cardiac events after asymptomatic perioperative acute coronary syndrome
2008-004016-12Phase 3Active
- Sponsor
- Lijf en Leven
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of clopidogrel in acute coronary syndrome (ACS) and atherosclerotic disease (2 arms), sponsored by Lijf en Leven. Primary endpoint: Primary composite cardiovascular outcome. Started Sep 2008; status: active.
02
Drugs
clopidogrel
03
Conditions
acute coronary syndrome (ACS)atherosclerotic disease
Beyond the preview
Go deeper on 2008-004016-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004016-12.